Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 2/3 × Tuberous Sclerosis × Everolimus × Clear all

Phase

Phase 2 5 Phase 1/2 3 Phase 4 2 Phase 3 2 Phase 2/3 2 Phase 1 1

Status

Withdrawn 1 Unknown 1

Sponsor Class

Study Type

Interventional 2

Sponsor

Conditions

Tuberous Sclerosis 2 Autistic Disorder 2 Uterine Neoplasms 1 Neuroendocrine Tumors 1 Neoplasm Metastasis 1 Intellectual Disability 1 Hamartoma Syndrome, Multiple 1 Gastroenteropancreatic Neuroendocrine Tumors 1 Gallbladder Neoplasms 1 Adenoma, Islet Cell 1

Interventions

Sirolimus 2 Everolimus 2 Vigabatrin 1 Fluid Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02860494 2021-05-03

EVEROST

Hospices Civils de Lyon

Phase 2/3 Withdrawn

Tuberous Sclerosis

NCT01730209 2015-05-05

RAPIT

Erasmus Medical Center

Phase 2/3 Unknown

Autistic Disorder, Intellectual Disability, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡